Market Overview:
The global bone and mineral metabolism disorders treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of bone and mineral metabolism disorders, rising geriatric population, and technological advancements in the field of bone and mineral metabolism disorders treatment. Based on type, the bisphosphonates segment accounted for the largest share of the global bone and mineral metabolism disorders treatment market in 2017. Bisphosphonates are used for treating various types of bone diseases such as osteoporosis, Paget’s disease, cancer-related metastatic bones lesions, hypercalcemia of malignancy (HCM), and multiple myeloma. They are also used for preventing skeletal-related events (SREs) in patients with advanced cancer. The estrogens segment is expected to grow at a highest CAGR during the forecast period owing to their ability to improve overall health by reducing inflammation levels and maintaining healthy bones density in postmenopausal women. Based on application, hospital pharmacies accounted for the largest share of the global Bone Mineral Metabolism Disorders Treatment Market in 2017 followed by retail pharmacies segments respectively . However , online pharmacies segment is projected register highest CAGR over forecast period due growing trend among people preferring purchase medicines through internet . Regionally , North America commanded largest revenue share followed by Europe Bone Mineral Metabolism Disorders Treatment Market In 2017 .
Product Definition:
Bone and mineral metabolism disorders treatment is the medical treatment of disorders that affect the bones or minerals in the body. These disorders can lead to problems with bone growth, density, and strength. Treatment may include medications, dietary changes, and exercise. The importance of bone and mineral metabolism disorder treatment is that it can help prevent or reduce problems with bones or minerals in the body.
Bisphosphonates:
Bisphosphonates are a group of chemical compounds that act as bone growth factors. They stimulate the bone cell to divide and grow, ultimately leading to increased bone mineral density. The most commonly used type of bisphosphonate is Alendronate (FOS), which functions by increasing the rate at which new osteoid tissue is formed in bones.
Estrogens:
Estrogens and it’s usage in Bone and Mineral Metabolism Disorders (BMD) treatment market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of bone disorders such as osteoporosis, osteoarthritis, anemia, etc. Furthermore, growing geriatric population base which is more prone towards these disorders coupled with rising awareness about BMD treatments are some high impact rendering drivers for this market.
Application Insights:
The drug stores application segment dominated the market with a share of over 60% in 2017. The growing usage of bone and mineral metabolism drugs for treating osteoporosis, osteopenia, and rheumatoid arthritis is one of the key factors driving this segment growth. Moreover, increasing awareness about these disorders among patients is expected to boost demand from drug stores over the next few years.
The hospital pharmacies are anticipated to register significant growth during the forecast period due to rising prevalence of chronic diseases such as cancer and diabetes which require long-term medication. Hospital pharmacies offer bulk purchasing power enabling them to offer discounts that average pharmacy owners cannot match; this factor is likely to drive hospital pharmacy sales in bone and mineral metabolism disorder treatments significantly over the forecast period.
Regional Analysis:
North America dominated the global bone and mineral metabolism disorders treatment market in 2017. The presence of a large number of key players, favorable reimbursement scenario, high healthcare expenditure and awareness regarding osteoporosis diagnosis & treatment are some factors attributing to its largest share. In addition, increasing R&D activities by various organizations is also expected to contribute towards the growth of this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China & India. Moreover, an increase in consumer awareness about osteoporosis care will further boost revenue generation prospects for this region during the estimated time span. Increasing incidence rates coupled with growing demand for cost-effective treatments are projected to impel regional expansion efforts by major pharmaceutical companies operating within Asia Pacific region over next few years (see Table 1).
Growth Factors:
- Increasing incidence of bone and mineral metabolism disorders
- Growing awareness about bone and mineral metabolism disorders among people
- Rising demand for better treatment options for bone and mineral metabolism disorders
- Technological advancements in the field of bone and mineral metabolism disorder treatment 5. Availability of government funding for research on bone and mineral metabolism disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Bone and Mineral Metabolism Disorders Treatment Market Research Report
By Type
Bisphosphonates, Estrogens, Phosphate Binders, Non-Calcium, Non-Metal-Based Binder, Metal-Based Binders, Magnesium-Based Binders, Vitamin D Analogs and Supplements, Calcimimetic Agents, Calcium and Magnesium Supplements
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
By Companies
Merck, F. Hoffmann-La Roche, Novartis, Warner Chilcott, Sanofi, AbbVie, Amgen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Bone and Mineral Metabolism Disorders Treatment Market Report Segments:
The global Bone and Mineral Metabolism Disorders Treatment market is segmented on the basis of:
Types
Bisphosphonates, Estrogens, Phosphate Binders, Non-Calcium, Non-Metal-Based Binder, Metal-Based Binders, Magnesium-Based Binders, Vitamin D Analogs and Supplements, Calcimimetic Agents, Calcium and Magnesium Supplements
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- F. Hoffmann-La Roche
- Novartis
- Warner Chilcott
- Sanofi
- AbbVie
- Amgen
Highlights of The Bone and Mineral Metabolism Disorders Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bisphosphonates
- Estrogens
- Phosphate Binders
- Non-Calcium, Non-Metal-Based Binder
- Metal-Based Binders
- Magnesium-Based Binders
- Vitamin D Analogs and Supplements
- Calcimimetic Agents
- Calcium and Magnesium Supplements
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bone and Mineral Metabolism Disorders Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bone and mineral metabolism disorders treatment typically includes medications to help the body produce more bone or minerals, physical therapy to improve muscle function and balance, and a healthy diet.
Some of the key players operating in the bone and mineral metabolism disorders treatment market are Merck, F. Hoffmann-La Roche, Novartis, Warner Chilcott, Sanofi, AbbVie, Amgen.
The bone and mineral metabolism disorders treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bone and Mineral Metabolism Disorders Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bone and Mineral Metabolism Disorders Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bone and Mineral Metabolism Disorders Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bone and Mineral Metabolism Disorders Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bone and Mineral Metabolism Disorders Treatment Market Size & Forecast, 2018-2028
4.5.1 Bone and Mineral Metabolism Disorders Treatment Market Size and Y-o-Y Growth
4.5.2 Bone and Mineral Metabolism Disorders Treatment Market Absolute $ Opportunity
Chapter 5 Global Bone and Mineral Metabolism Disorders Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Type
5.2.1 Bisphosphonates
5.2.2 Estrogens
5.2.3 Phosphate Binders
5.2.4 Non-Calcium
5.2.5 Non-Metal-Based Binder
5.2.6 Metal-Based Binders
5.2.7 Magnesium-Based Binders
5.2.8 Vitamin D Analogs and Supplements
5.2.9 Calcimimetic Agents
5.2.10 Calcium and Magnesium Supplements
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bone and Mineral Metabolism Disorders Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bone and Mineral Metabolism Disorders Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bone and Mineral Metabolism Disorders Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Type
9.6.1 Bisphosphonates
9.6.2 Estrogens
9.6.3 Phosphate Binders
9.6.4 Non-Calcium
9.6.5 Non-Metal-Based Binder
9.6.6 Metal-Based Binders
9.6.7 Magnesium-Based Binders
9.6.8 Vitamin D Analogs and Supplements
9.6.9 Calcimimetic Agents
9.6.10 Calcium and Magnesium Supplements
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bone and Mineral Metabolism Disorders Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Type
10.6.1 Bisphosphonates
10.6.2 Estrogens
10.6.3 Phosphate Binders
10.6.4 Non-Calcium
10.6.5 Non-Metal-Based Binder
10.6.6 Metal-Based Binders
10.6.7 Magnesium-Based Binders
10.6.8 Vitamin D Analogs and Supplements
10.6.9 Calcimimetic Agents
10.6.10 Calcium and Magnesium Supplements
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bone and Mineral Metabolism Disorders Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Type
11.6.1 Bisphosphonates
11.6.2 Estrogens
11.6.3 Phosphate Binders
11.6.4 Non-Calcium
11.6.5 Non-Metal-Based Binder
11.6.6 Metal-Based Binders
11.6.7 Magnesium-Based Binders
11.6.8 Vitamin D Analogs and Supplements
11.6.9 Calcimimetic Agents
11.6.10 Calcium and Magnesium Supplements
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bone and Mineral Metabolism Disorders Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Type
12.6.1 Bisphosphonates
12.6.2 Estrogens
12.6.3 Phosphate Binders
12.6.4 Non-Calcium
12.6.5 Non-Metal-Based Binder
12.6.6 Metal-Based Binders
12.6.7 Magnesium-Based Binders
12.6.8 Vitamin D Analogs and Supplements
12.6.9 Calcimimetic Agents
12.6.10 Calcium and Magnesium Supplements
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bone and Mineral Metabolism Disorders Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Type
13.6.1 Bisphosphonates
13.6.2 Estrogens
13.6.3 Phosphate Binders
13.6.4 Non-Calcium
13.6.5 Non-Metal-Based Binder
13.6.6 Metal-Based Binders
13.6.7 Magnesium-Based Binders
13.6.8 Vitamin D Analogs and Supplements
13.6.9 Calcimimetic Agents
13.6.10 Calcium and Magnesium Supplements
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bone and Mineral Metabolism Disorders Treatment Market: Competitive Dashboard
14.2 Global Bone and Mineral Metabolism Disorders Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 F. Hoffmann-La Roche
14.3.3 Novartis
14.3.4 Warner Chilcott
14.3.5 Sanofi
14.3.6 AbbVie
14.3.7 Amgen
